Skip to main content
. 2019 Nov 6;36(12):177. doi: 10.1007/s11095-019-2702-8

Fig. 3.

Fig. 3

Comparison of docetaxel in combination with trastuzumab (EU), ABP 980, and trastuzumab (US) on the growth of NCI N87 Cells. Graph shows the percent growth inhibition for representative test samples in the presence and absence of docetaxel as compared with an untreated control. Unique lots are shown for ABP 980 (red), trastuzumab (US) (black), and trastuzumab (EU) (blue). Each point is a mean of 6 replicates (±SE). Abbreviations: trastuzumab (EU) EU authorized trastuzumab, trastuzumab (US) FDA licensed trastuzumab.